Induced degradation of glycosaminoglycans in Hurler's and Hunter's syndromes by plasma infusion.
about
Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of miceThe mucopolysaccharidoses.Replacement therapy in the mucopolysaccharidosesMucopolysaccharidoses and mucolipidoses.Long-term effects of bone marrow transplantation in dogs with mucopolysaccharidosis I.Enzyme replacement therapy for the mucopolysaccharide storage disorders.The defect in the Hurler and Scheie syndromes: deficiency of -L-iduronidaseHematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines.N-acetylgalactosamine-6-sulfate sulfatase in man. Absence of the enzyme in Morquio diseaseInborn errors of metabolism: principles and their applications.The Hurler syndrome: a study of cultured lymphoid cell linesMetabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfataseEnzyme replacement therapy by fibroblast transplantation: long-term biochemical study in three cases of Hunter's syndrome.Emerging trends in transplantation of inherited metabolic diseases.Effect of leukocyte transfusion in a child with type II mucopolysaccharidosis.Current and emerging management options for patients with Morquio A syndromeQuantitative aspects of pinocytosis and the intracellular fate of N-acetyl-alpha-D-glucosaminidase in Sanfilippo B fibroblastsThe future for gene therapy--a reevaluation.Colorimetric measurement of dermatan sulphate.An inverse relationship between heparin content and antibody response in genetically selected mice. Sex effect and evidence of a polygenic control for skin heparin concentration.Cell therapy for diverse central nervous system disorders: inherited metabolic diseases and autism.Hunter's syndrome and Cooley's anaemia in the same patient. Effect of multiple transfusions.
P2860
Q24626527-8F2254C6-BAE4-4322-90D0-334B1DF534E4Q33586932-D8757A99-1158-4D3D-8E43-B47E5C7F62D2Q33678920-0C9681EC-898F-408F-B667-CEC748E81400Q34302974-914DAA8C-C4D2-4440-85F5-87CD66936BFBQ34425239-E78D1FBC-FF70-4165-B286-BB4C497933F3Q34628680-FB7D8BD6-E359-4E08-87FC-F4CD4BF94C23Q34719775-A25DAE41-08A9-4322-97FB-2656921456CFQ35079584-AD019C60-BF27-4703-B003-7E6F81683B6AQ35200047-D5F8F57B-5DE9-461A-9D89-27DE0A18B29FQ35926081-5ED8266E-7198-4F3A-906A-59D8F6BC3ABBQ36271914-7EF1C83C-052E-4265-BE5A-759E2046896EQ36728931-72142FDF-B38A-418B-813F-1443B5CB791AQ37035071-9C959FE3-BD4B-43A3-999F-0096C8E7E74EQ37051044-2188DE76-A85B-4621-86EF-1C8C21DC37CEQ37482680-F0EAFB87-62F5-4D44-B47E-242B7E1A52F3Q38081868-9AB1E800-EEE9-4AB5-87C5-9E3F4FB429ACQ40367761-F2DDCFB5-6143-4037-9EC9-6F632480648AQ41523080-767AE9A7-3BF6-4F03-BB4F-82EB7049C85DQ42093363-2C45D1A1-CBD8-413E-8F4A-318DD9C8C369Q42868531-73248280-07B0-4B2B-9504-02556A26429CQ49557884-40BC860F-8822-4FD2-8ED3-001CF0CB3162Q54141031-AD4C20E3-DE99-433B-A305-E846FFFD98AF
P2860
Induced degradation of glycosaminoglycans in Hurler's and Hunter's syndromes by plasma infusion.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1971
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Induced degradation of glycosa ...... syndromes by plasma infusion.
@en
Induced degradation of glycosa ...... syndromes by plasma infusion.
@nl
type
label
Induced degradation of glycosa ...... syndromes by plasma infusion.
@en
Induced degradation of glycosa ...... syndromes by plasma infusion.
@nl
prefLabel
Induced degradation of glycosa ...... syndromes by plasma infusion.
@en
Induced degradation of glycosa ...... syndromes by plasma infusion.
@nl
P2093
P2860
P356
P1476
Induced degradation of glycosa ...... syndromes by plasma infusion.
@en
P2093
Berglund RK
Di Ferrante N
Donnelly PV
Hrgovcic R
Nichols BL
P2860
P304
P356
10.1073/PNAS.68.2.303
P407
P577
1971-02-01T00:00:00Z